🔗 Share this article

Chancellor Reeves has revealed she is preparing "specific action to address cost of living issues" in next month's Budget.

In comments to media outlets, she emphasized that curbing price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's price growth is expected to be the highest among the G7 developed nations this calendar year and the following year.

Potential Energy Bill Interventions

It is understood the government could take action to lower utility costs, for instance by reducing the present 5% level of value-added tax applied on energy supplies.

An additional option is to reduce some of the regulatory levies presently added to bills.

Fiscal Constraints and Analyst Predictions

The administration will obtain the next assessment from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these actions.

The consensus from the majority of economists is that the Chancellor will have to introduce tax increases or spending cuts in order to meet her voluntary fiscal targets.

Previously on the same day, estimates showed there was a twenty-two billion pound gap for the chancellor to resolve, which is at the lower end of forecasts.

"There's a shared task between the Bank of England and the administration to bear down further on some of the sources of price increases," Reeves told reporters in the US capital, at the annual meetings of the IMF and World Bank.

Revenue Pledges and International Issues

While a great deal of the attention has been on likely tax rises, the chancellor said the latest figures from the OBR had not altered her pledge to election pledges not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and trade issues for the fiscal revenue measures, likely to be directed on those "wealthiest."

International Economic Tensions

Addressing worries about the UK's trade ties with China she said: "Our national security always come first."

Last week's statement by China to strengthen export controls on critical minerals and other resources that are essential for advanced tech manufacturing led American leader the US President to suggest an further 100% tariff on goods from China, increasing the prospect of an all-out trade war between the two global powers.

The American finance chief described China's action "economic coercion" and "a international production power grab."

Asked about considering the American proposal to join its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the action was "harmful for the world economy and generates further headwinds."

"I believe there are areas where we need to confront Chinese policies, but there are also important opportunities to trade with China's economy, including banking sector and other areas of the economic system. We've got to get that balance appropriate."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own essential resources strategy, so that we are more independent."

Health Service Drug Pricing and Investment

Reeves also admitted that the cost the NHS spends on pharmaceuticals could increase as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the world's largest drug companies have said lately that they are either delaying or abandoning operations in the UK, with some blaming the low prices they are getting.

Recently, the Science Minister said the cost the health service spends on drugs would have to go up to stop companies and drug research funding departing from the UK.

The Chancellor informed the BBC: "It has been observed due to the pricing regime, that medical research, new drugs have not been available in the UK in the way that they are in other European countries."

"Our aim is to ensure that patients receiving treatment from the National Health Service are able to obtain the best essential treatments in the globe. And so we are looking at all of that, and... looking to attract more funding into Britain."